Mylan launches generic Fortamet(R) tablets
Mylan announced the U.S. launch of Metformin Hydrochloride ER Tablets USP, 500 mg and 1000 mg, a generic version of Watson's Fortamet®. Mylan received final FDA approval for its ANDA which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. September 30, 2016